Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04036435
Other study ID # IM011-075
Secondary ID 2019-000612-29
Status Active, not recruiting
Phase Phase 3
First received
Last updated
Start date August 12, 2019
Est. completion date July 26, 2026

Study information

Verified date September 2023
Source Bristol-Myers Squibb
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The main purpose of this study is to characterize the long-term safety and efficacy of the drug Deucravacitinib (BMS-986165) in patients who have been previously enrolled in an applicable Phase 3 psoriasis study.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 1452
Est. completion date July 26, 2026
Est. primary completion date July 25, 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Completion of the protocol-required treatment period in an applicable study of BMS-986165 in moderate-to-severe psoriasis - Women must not be pregnant, lactating, or breastfeeding Exclusion Criteria: - Any disease or medical condition that the investigator feels that would make the patient unsuitable for this study. - To be eligible for the study, a participant must not have active signs or symptoms of tuberculosis (TB) as judged by the investigator. Other protocol-defined inclusion/exclusion criteria apply

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
BMS-986165
Specified dose on specified days

Locations

Country Name City State
Australia The Skin Centre Benowa Queensland
Australia Local Institution - 0245 Box Hill Victoria
Australia Skin and Cancer Foundation Carlton Victoria
Australia Holdsworth House Medical Practice Darlinghurst New South Wales
Australia Sinclair Dermatology East Melbourne Victoria
Australia North Eastern Health Specialists Hectorville South Australia
Australia St. George Dermatology & Skin Care Centre Kogarah New South Wales
Australia Local Institution - 0251 Parkville Victoria
Australia Local Institution - 0247 Perth Western Australia
Australia Woden Dermatology Phillip Australian Capital Territory
Australia Local Institution - 0250 Westmead New South Wales
Australia Veracity Clinical Research Woolloongabba Queensland
Canada CCA Medical Research Ajax Ontario
Canada Beacon Dermatology Calgary Alberta
Canada Stratica Medical Edmonton Alberta
Canada Local Institution - 0090 London Ontario
Canada Mediprobe Research London Ontario
Canada Lynderm Research Markham Ontario
Canada DermEdge Mississauga Ontario
Canada Docteur David Gratton Dermatologue Montreal Quebec
Canada Siena Medical Research Montreal Quebec
Canada North Bay Dermatology Centre North Bay Ontario
Canada Office of Dr. Niakosari Firouzeh North York Ontario
Canada Institute of Cosmetic and Laser Surgery Oakville Ontario
Canada Local Institution - 0088 Peterborough Ontario
Canada Local Institution - 0258 Quebec
Canada Local Institution - 0082 Richmond Hill Ontario
Canada SkinFit MD Laser and Cosmetic Clinic Surrey British Columbia
Canada Local Institution - 0132 Toronto Ontario
Canada Toronto Dermatology Centre Toronto Ontario
Canada University of British Columbia Vancouver British Columbia
Canada Kim Papp Clinical Research Waterloo Ontario
Canada XLR8 Medical Research Windsor Ontario
Canada Wiseman Dermatology Research Winnipeg Manitoba
China Local Institution Beijing Beijing
China Local Institution Beijing Beijing
China Local Institution Changchun Jilin
China Local Institution Chengdu Sichuan
China Local Institution Chongqing Chongqing
China Local Institution Dalian Liaoning
China Local Institution Hangzhou Zhejiang
China Local Institution Hangzhou Zhejiang
China Local Institution Hangzhou Zhejiang
China Local Institution Hangzhou Zhejiang
China Local Institution - 0312 Nanjing Jiangsu
China Local Institution - 0292 Shanghai Shanghai
China Local Institution Taiyuan Shan1xi
China Local Institution Wuhan Hubei
China Local Institution Wuhan Hubei
Czechia Nemocnice Jihlava Jihlava 1
Czechia Nemocnice Novy Jicin a.s. Novy Jicin
Czechia MUDr. Helena Korandova Olomouc
Czechia Fakultni Nemocnice Ostrava Ostrava
Czechia Sanatorium profesora Arenbergera Praha 1
Czechia Clintrial Praha 10
Czechia Krajska zdravotni - Masarykova nemocnice v Usti nad Labem Usti nad Labem
Finland Local Institution - 0279 Tampere
France Centre Hospitalier Universitaire de Nice Hopital lArchet Nice cedex 3
Germany Licca Clinical Research Institute Augsburg
Germany Hautarztpraxis Dr. Niesmann & Dr. Othlinghaus Bochum
Germany Hautarztpraxis Dr. Beatrice Gerlach Dresden
Germany Synexus Frankfurt Clinical Research Frankfurt am Main
Germany Local Institution - 0263 Hamburg
Germany Dermakiel - Allergie Und Haut Centrum Kiel
Germany Praxis Dr. Beate Schwarz Langenau
Germany Praxis Dr. med. Wilfried Steinborn Straubing
Germany CentroDerm Privatklinik Wuppertal
Hungary Qualiclinic Egeszsegugyi Szolgaltato es Kutatasszervezo Kft. Budapest
Hungary Semmelweis Egyetem Budapest
Hungary Synexus Magyarorszag Budapest
Hungary Debreceni Egyetem Klinikai Kozpont Debrecen
Hungary Synexus Magyarorszag Egeszsegugyi Szolgaltato - Debrecen Affiliated Site Debrecen
Hungary Synexus Magyarorszag Egeszsegugyi Szolgaltato - Gyula Gyula
Hungary Josa Andras Oktatokorhaza - Szabolcs Szatmar-Bereg Megyei Onkormanyzat Nyiregyhaza
Hungary Pecsi Tudomanyegyetem Klinikai Kozpont Pecs
Hungary Allergo-Derm Bakos Szolnok
Hungary Synexus Magyarorszag Egeszsegugyi Szolgaltato - Zalaegerszeg Zalaegerszeg
Israel Local Institution - 0237 Haifa
Israel Local Institution Petah Tikva
Israel Local Institution Ramat Gan
Japan Fukuoka University Hospital Fukuoka-shi Fukuoka
Japan Hamamatsu University Hospital Hamamatsu Shizuoka
Japan Tokai University Hospital Isehara City Kanagawa
Japan Nihon University Itabashi Hospital Itabashi-ku Tokyo
Japan Teikyo University Hospital Itabashi-Ku Tokyo
Japan Kobe University Hospital Kobe Hyogo
Japan Kumamoto University Hospital Kumamoto
Japan Kurashiki Central Hospital Kurashiki Okayama
Japan Kyoto University Hospital Kyoto-City Kyoto
Japan Local Institution - 0066 Kyoto-city Kyoto
Japan Local Institution - 0072 Matsumoto Nagano
Japan The Jikei University Hospital Minato-ku Tokyo
Japan Local Institution - 0065 Nagoya Aichi
Japan Local Institution - 0076 Nankoku Kochi
Japan Local Institution - 0067 Osaka
Japan Local Institution - 0073 Osaka
Japan Sapporo Skin Clinic Sapporo Hokkaido
Japan Jichi Medical University Hospital Shimotsuke Tochigi
Japan Local Institution - 0062 Shinagawa Tokyo
Japan Japan Community Health Care Organization Tokyo Yamate Medical Center Shinjuku-ku Tokyo
Japan Tokyo Medical University Hospital Shinjuku-ku Tokyo
Japan Mie University Hospital Tsu MIE
Japan Yokohama City University Hospital Yokohama Kanagawa
Japan Local Institution - 0075 Yokohama-Shi Kanagawa
Korea, Republic of Local Institution Bucheon-si
Korea, Republic of Local Institution - 0054 Busan
Korea, Republic of Local Institution Goyang-si
Korea, Republic of Local Institution - 0310 Gwangju
Korea, Republic of Local Institution Hwaseong-si
Korea, Republic of Local Institution Incheon
Korea, Republic of Local Institution Incheon
Korea, Republic of Local Institution Seongnam-si
Korea, Republic of Local Institution - 0051 Seongnam-si
Korea, Republic of Local Institution Seoul
Korea, Republic of Local Institution Seoul
Korea, Republic of Local Institution Seoul
Korea, Republic of Local Institution Seoul
Korea, Republic of Local Institution - 0053 Seoul
Korea, Republic of Local Institution - 0055 Seoul
Korea, Republic of Local Institution - 0305 Seoul
Korea, Republic of Local Institution Suwon
New Zealand Local Institution Mount Cook
New Zealand Local Institution Tauranga
Poland ClinicMed Daniluk Nowak Spolka Jawna Bialystok
Poland Local Institution - 0104 Bialystok
Poland ZDROWIE OSTEO-MEDIC s.c. Lidia i Artur Racewicz, Agnieszka i Jerzy Supronik Bialystok
Poland Centrum Kliniczno Badawcze J Brzezicki B Gornikiewicz Brzezicka Lekarze Spolka Partnerska Elblag
Poland Local Institution - 0149 Gdansk
Poland Synexus Polska Oddzial w Gdyni Gdynia
Poland Zespol Naukowo-Leczniczy Iwolang Iwonicz-Zdroj
Poland Synexus - Katowice Katowice
Poland Pratia MCM Krakow Krak
Poland Krakowskie Centrum Medyczne Krakow
Poland Centrum Medyczne All-Med Lodz
Poland Centrum Terapii Wspolczesnej Lodz
Poland Local Institution - 0114 Lodz
Poland Local Institution - 0144 Lodz
Poland Niepubliczny Zaklad Opieki Zdrowotnej MED-LASER Lublin
Poland Miejski Szpital Zespolony w Olsztynie Olsztyn
Poland DermoDent - Centrum Medyczne Czajkowscy Osielsko
Poland Local Institution - 0103 Poznan
Poland Solumed Centrum Medyczne Poznan
Poland ETG - Siedlce Siedlce
Poland ETG - Skierniewice Skierniewice
Poland Local Institution - 0125 Torun
Poland Local Institution - 0111 Warsaw
Poland Clinical Research Group Warszawa
Poland ETG - Warszawa Warszawa
Poland High-Med Przychodnia Specjalistyczna Warszawa
Poland Local Institution - 0138 Warszawa MZ
Poland Local Institution - 0137 Wroc?aw
Poland Centrum Medyczne Oporow Wroclaw
Poland dermMedica Sp. z o.o. Wroclaw
Poland Local Institution - 0124 Wroclaw
Puerto Rico Local Institution - 0289 San Juan
Russian Federation Local Institution - 0178 Ekaterinburg
Russian Federation Local Institution - 0172 Kazan
Russian Federation Local Institution - 0187 Krasnodar
Russian Federation Local Institution - 0169 Moscow
Russian Federation Local Institution - 0171 Moscow
Russian Federation Local Institution - 0175 Moscow
Russian Federation Local Institution - 0190 Ryazan
Russian Federation Local Institution - 0179 Saint Petersburg
Russian Federation Local Institution - 0182 Saint Petersburg
Russian Federation Local Institution - 0201 Saint Petersburg
Russian Federation Local Institution - 0202 Saratov
Russian Federation Local Institution - 0184 Smolensk
Russian Federation Local Institution - 0222 Yaroslavl
Spain Local Institution - 0223 Alcorcon
Spain Hospital Universitari Germans Trias i Pujol Badalona
Spain Hospital Universitario Cruces Barakaldo
Spain Local Institution - 0225 Cordoba
Spain Local Institution - 0226 Las Palmas De Gran Canaria
Spain Hospital Universitario Ramon Y Cajal Madrid
Spain Local Institution - 0227 Malaga
Spain Hospital de Manises Manises
Spain Hospital Universitario Quironsalud Madrid Pozuelo de Alarcon
Sweden Ladulaas Kliniska Studier Boras
Sweden ProbarE i Lund Lund
Sweden Local Institution - 0186 Solna
Taiwan Local Institution - 0079 Kaohsiung
Taiwan Local Institution - 0297 Kaohsiung
Taiwan Local Institution Taipei
Taiwan Local Institution Taipei
Taiwan Local Institution Taipei
Taiwan Local Institution - 0153 Taipei
Taiwan Local Institution Taipei City
United Kingdom MAC Clinical Research - Cannock Cannock
United Kingdom Synexus - Lancashire Clinical Research Centre Chorley
United Kingdom Synexus - Manchester Clinical Research Centre Chorley
United Kingdom Synexus - Merseyside Clinical Research Centre Chorley
United Kingdom Mounts Bay Medical Cornwall
United Kingdom The Dudley Group NHS Foundation Trust Dudley
United Kingdom MAC Clinical Research - Stockton Durham
United Kingdom MAC Clinical Research - Blackpool Lancashire
United Kingdom Burbage Surgery Leicestershire
United Kingdom Guys and Saint Thomas NHS Foundation Trust London
United Kingdom MAC Clinical Research - Manchester Manchester
United Kingdom Salford Royal NHS Foundation Trust Manchester
United Kingdom MAC Clinical Research - Liverpool Prescot
United States Radiant Research - Anderson Anderson South Carolina
United States David Fivenson MD Dermatology Ann Arbor Michigan
United States Local Institution - 0006 Arlington Texas
United States Bellaire Dermatology Bellaire Texas
United States Hassman Research Institute Berlin New Jersey
United States Local Institution - 0278 Birmingham Alabama
United States Total Skin and Beauty Dermatology Center Birmingham Alabama
United States Local Institution - 0170 Boca Raton Florida
United States Local Institution - 0291 Boston Massachusetts
United States Tufts Medical Center Boston Massachusetts
United States New England Research Associates Bridgeport Connecticut
United States Montefiore Medical Center - Bronx Bronx New York
United States PMG Research of Cary Cary North Carolina
United States Clinical Research Center of the Carolinas Charleston South Carolina
United States Ora Chestnut Hill Massachusetts
United States ClinOhio Research Services Columbus Ohio
United States Radiant Research - Columbus Columbus Ohio
United States Local Institution - 0015 Dallas Texas
United States Local Institution - 0030 Dallas Texas
United States Local Institution - 0195 Dallas Texas
United States Menter Dermatology Research Institute Dallas Texas
United States ERN - Accel Research Sites DeLand Florida
United States Local Institution - 0016 East Windsor New Jersey
United States Clinical Research Advantage - Evansville - South Kenmore Drive Evansville Indiana
United States Deaconess Clinic Downtown Evansville Indiana
United States Local Institution - 0045 Exton Pennsylvania
United States Local Institution - 0176 Fairborn Ohio
United States Hamzavi Dermatology Fort Gratiot Michigan
United States Johnson Dermatology Fort Smith Arkansas
United States First OC Dermatology & Belle-Aimee Skincare Clinic Fountain Valley Fountain Valley California
United States Local Institution - 0206 Fresno California
United States Rivergate Dermatology - Main Office Goodlettsville Tennessee
United States Local Institution - 0037 Greer South Carolina
United States Indago Research and Health Center Hialeah Florida
United States Burke Pharmaceutical Research Hot Springs Arkansas
United States Center for Clinical Studies - Texas Medical Center Houston Texas
United States Dawes Fretzin Dermatology Group Indianapolis Indiana
United States Local Institution - 0017 Irvine California
United States Clinical Research Solutions - Jackson Jackson Tennessee
United States Forest Hills Dermatology Group Kew Gardens New York
United States Dermatology Associates of Knoxville Knoxville Tennessee
United States The Skin Wellness Center Knoxville Tennessee
United States Shondra L. Smith, M.D. Lake Charles Louisiana
United States Clinical Research Consortium - Las Vegas Las Vegas Nevada
United States Interspond - Long Beach Clinical Trials Long Beach California
United States Dermatology Research Associates - Los Angeles Los Angeles California
United States Local Institution - 0236 Los Angeles California
United States Local Institution - 0040 Louisville Kentucky
United States Local Institution - 0013 Marietta Georgia
United States Treasure Valley Dermatology & Skin Cancer Center Meridian Idaho
United States Local Institution - 0234 Methuen Massachusetts
United States International Dermatology Research Miami Florida
United States LCC Medical Research Miami Florida
United States Local Institution - 0216 Miami Florida
United States Well Pharma Medical Research Miami Florida
United States Interspond - Savin Medical Group Miami Lakes Florida
United States Local Institution - 0007 Miami Lakes Florida
United States Clinical Trials of America - Monroe Monroe Louisiana
United States Associated Skin Care Specialists - Minnesota Clinical Study Center New Brighton Minnesota
United States Local Institution - 0058 New York New York
United States Central Sooner Research Norman Oklahoma
United States Coastal Carolina Research Center - Mount Pleasant North Charleston South Carolina
United States Unity Clinical Research Oklahoma City Oklahoma
United States Austin Institute for Clinical Research - Pflugerville Pflugerville Texas
United States Alliance Dermatology and Mohs Center - Phoenix Phoenix Arizona
United States Arizona Research Center Phoenix Arizona
United States Local Institution - 0282 Pittsburgh Pennsylvania
United States Local Institution - 0020 Plainfield Indiana
United States Local Institution - 0198 Port Orange Florida
United States Local Institution - 0009 Portland Oregon
United States Local Institution - 0167 Portland Oregon
United States DermCare Experts Quincy Massachusetts
United States Local Institution - 0004 Rapid City South Dakota
United States Northwest Arkansas Clinical Trials Center, PLLC Rogers Arkansas
United States Washington University School of Medicine - West County Dermatology Saint Louis Missouri
United States Dermatology Clinical Research Center of San Antonio San Antonio Texas
United States University of Texas Health Science Center at San Antonio San Antonio Texas
United States Therapeutics Clinical Research San Diego California
United States University Dermatology Group San Diego California
United States University of California San Diego Health Systems San Diego California
United States Local Institution - 0094 San Luis Obispo California
United States Local Institution - 0235 Sandy Springs Georgia
United States Clinical Science Institute Santa Monica California
United States NorthBay Clinical Research Santa Rosa California
United States Synexus - Santa Rosa Santa Rosa California
United States Local Institution - 0265 Seattle Washington
United States Local Institution - 0042 Sherman Oaks California
United States The South Bend Clinic South Bend Indiana
United States Springfield Clinic Springfield Illinois
United States Stamford Therapeutics Consortium Stamford Connecticut
United States Local Institution - 0218 Stony Brook New York
United States Interspond - Acclaim Dermatology Sugar Land Texas
United States Interspond - Houston Center for Clinical Research Sugar Land Texas
United States Local Institution - 0008 Tampa Florida
United States Local Institution - 0233 Tampa Florida
United States Local Institution - 0025 Troy Michigan
United States Synexus - Orange Grove Family Practice Tucson Arizona
United States Care Access Research - Walnut Creek Walnut Creek California
United States Center for Clinical Studies - Webster Webster Texas
United States Dundee Dermatology West Dundee Illinois
United States Wilmington Dermatology Center Wilmington North Carolina

Sponsors (1)

Lead Sponsor Collaborator
Bristol-Myers Squibb

Countries where clinical trial is conducted

United States,  Australia,  Canada,  China,  Czechia,  Finland,  France,  Germany,  Hungary,  Israel,  Japan,  Korea, Republic of,  New Zealand,  Poland,  Puerto Rico,  Russian Federation,  Spain,  Sweden,  Taiwan,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence of Adverse Events (AEs) Up to 244 weeks
Primary Incidence of Serious Adverse Events (SAEs) Up to 244 weeks
Secondary static Physician Global Assessment (sPGA) 0/1 response Up to 240 weeks
Secondary Psoriasis Area and Severity Index (PASI) 75 response Up to 240 weeks
See also
  Status Clinical Trial Phase
Completed NCT03236870 - A Study to Evaluate the Effectiveness and Patient-Reported Outcome of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in China
Completed NCT00078819 - Etanercept (Enbrel®) in Psoriasis - Pediatrics Phase 3
Completed NCT04841187 - Assessing the Long Term Effectiveness and Safety of Systemic Treatments in Cutaneous Psoriasis
Active, not recruiting NCT03927352 - The Purpose of This Research Study is to Compare the Efficacy and Safety of SCT630 and Adalimumab (HUMIRA®) in Adults With Plaque Psoriasis Phase 3
Completed NCT03284879 - Post-Marketing Surveillance Study of OTEZLA
Recruiting NCT06027034 - Effectiveness of a Digital Health Application for Psoriasis N/A
Not yet recruiting NCT06050330 - CD4+ T Cells and S100A7 Epression in Normal and Psoriatic Skin: A Histological and Histochemical Study N/A
Recruiting NCT05744466 - A Real-world Observational Study to Compare Effectiveness of Deucravacitinib Vs Apremilast in Adults With Plaque Psoriasis
Completed NCT04149587 - A Study of Brodalumab (SILIQ®) in Psoriasis Participants With Inadequate Response to Their Current Biologic Agent Regimen
Completed NCT01384630 - Safety, Pharmacokinetics, and Efficacy of RA-18C3 in Subjects With Moderate to Severe Psoriasis Phase 2
Completed NCT03998683 - A Study of Guselkumab for the Treatment of Palmoplantar-non-Pustular Psoriasis Phase 3
Terminated NCT03556202 - A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3) Phase 3
Completed NCT05051943 - A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
Recruiting NCT06077331 - A Study to Evaluate Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis Phase 2
Completed NCT04316585 - A Study to Evaluate the Benefit and Safety of GSK2982772 in Moderate to Severe Psoriasis Participants Phase 1
Completed NCT04894890 - A Prospective Multicenter Study for the Assessment of Treatment Patterns, Effectiveness and Safety of Secukinumab in Adult Patients With Moderate to Severe Plaque Psoriasis in a Real-world Setting in China
Completed NCT00358384 - Chronic Plaque Psoriasis Study With Topical Formulation Of GW786034 Phase 1
Completed NCT03757013 - A Study to Assess Benefits of Apremilast in Patients With Moderate to Severe Chronic Plaque Psoriasis Followed by Dermatologists Under Real Life Settings in France
Completed NCT03265613 - Safety and Efficacy of Expanded Allogeneic AD-MSCs in Patients With Moderate to Severe Psoriasis Phase 1/Phase 2
Completed NCT05003531 - A Study to Evaluate IBI112 in the Treatment of Subjects With Moderate to Severe Plaque Psoriasis Phase 2